Onfi (Clobazam) Half-Life: How Long It Stays in the System
The half-life of Onfi (clobazam), how long this benzodiazepine and its active metabolite stay in the body, what this means for dosing and withdrawal, and the dependence risk.
Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist, Phuket Island Rehab.
Onfi, the brand name for clobazam, is a long-acting benzodiazepine, and it has a relatively long half-life, meaning it stays in the body for an extended time. The half-life of clobazam itself is generally in the region of around 36 to 42 hours, but importantly, clobazam is broken down by the body into an active metabolite called norclobazam, which has a much longer half-life, often cited as around 71 to 82 hours, so the active drug effectively remains in the system considerably longer than the parent drug alone. This long half-life means Onfi builds up in the body with regular dosing, can usually be taken once or twice daily, and has effects that persist over a long period, which is part of why it is useful for ongoing conditions such as certain seizures. It also means the drug clears the body slowly after stopping, which can make withdrawal somewhat more gradual than with short-acting benzodiazepines, though stopping must still be done by tapering under medical supervision. Onfi is a benzodiazepine and, like others in the class, carries risks of tolerance, dependence, and a dangerous withdrawal if stopped abruptly, so it should be taken only as prescribed and never stopped suddenly after regular use.
What is the half-life of Onfi (clobazam)?
Onfi, the brand name for the drug clobazam, is a benzodiazepine, and it has a relatively long half-life, meaning it stays in the body for an extended time. The half-life of a drug is the time it takes for the amount of the drug in the body to reduce by half, and it gives an indication of how long a drug remains active and how long it takes to clear. For clobazam, the half-life of the drug itself is generally in the region of around 36 to 42 hours, which is relatively long, making clobazam a long-acting benzodiazepine. However, the full picture of how long Onfi stays in the system involves not just clobazam itself but also its active metabolite, which is important to understand.
This article explains the half-life of Onfi (clobazam), including the crucial role of its long-acting active metabolite, how long the drug and its metabolite stay in the body, what this long half-life means for dosing and for withdrawal, and the dependence risk that, as a benzodiazepine, Onfi carries. The aim is a clear, accurate account of clobazam’s half-life and what it means in practice, which is relevant for understanding how the drug is dosed, how long its effects last, and what happens when it is stopped. Understanding the pharmacology of Onfi, particularly its long half-life and active metabolite, helps make sense of how it is used and the considerations around stopping it.
The active metabolite and the full picture
The most important point in understanding how long Onfi stays in the system is that clobazam is broken down by the body into an active metabolite, a substance produced when the body processes the drug, that is itself active and contributes to the drug’s effects. This metabolite, called norclobazam (or N-desmethylclobazam), has a much longer half-life than clobazam itself, often cited as around 71 to 82 hours, considerably longer than the roughly 36 to 42 hour half-life of clobazam. Because this active metabolite remains in the body much longer and contributes to the drug’s effects, the active drug effectively remains in the system considerably longer than the half-life of clobazam alone would suggest.
This means that the overall effect of Onfi is governed not just by clobazam but significantly by the long-lasting active metabolite. The presence of this long-acting metabolite is part of why Onfi is considered a long-acting benzodiazepine with persistent effects, and it has practical implications: the drug builds up in the body over the first days and weeks of regular dosing until it reaches a steady level, its effects are sustained over a long period, and it clears the body slowly after the drug is stopped. So when considering how long Onfi stays in the system and how long its effects last, it is essential to take into account both clobazam and its long-acting active metabolite, norclobazam, which together give the drug its long-acting character.
| Component | Approximate half-life |
|---|---|
| Clobazam (the drug itself) | Around 36-42 hours |
| Norclobazam (active metabolite) | Around 71-82 hours (much longer) |
| Overall character | Long-acting benzodiazepine |
| Effect of long half-life | Builds up; sustained effects; slow clearance |
| Dosing | Usually once or twice daily |
| On stopping | Clears slowly; still must be tapered |
What the long half-life means for dosing and effects
Onfi’s long half-life, especially because of its long-acting active metabolite, has several practical implications for how it is dosed and how its effects work. Because the drug and its metabolite remain in the body for an extended time, Onfi can usually be taken once or twice daily, rather than needing frequent doses, which is convenient for ongoing treatment. The long half-life also means that the drug accumulates in the body over the first days to weeks of regular dosing, building up until it reaches a stable, steady level, which is why the full effect may take some time to establish and why dose changes take time to fully show their effect. The sustained presence of the drug provides a steady, prolonged effect.
This long-acting profile is part of why Onfi is useful for ongoing conditions. Onfi (clobazam) is used particularly as an add-on treatment for seizures associated with a severe form of epilepsy, and its long-acting nature suits the need for steady, sustained control over time. The persistent effect and once- or twice-daily dosing are advantages for managing such an ongoing condition. As with any medication, Onfi should be taken exactly as prescribed by the doctor, and because of the way it builds up and the long half-life, dose adjustments are made carefully and their effects assessed over time. The long half-life is, in these respects, a useful feature of the drug for its intended uses, providing steady, prolonged treatment.
Implications for stopping and the dependence risk
The long half-life of Onfi also has implications for stopping the drug. Because clobazam and its active metabolite clear the body slowly, the drug levels fall more gradually after stopping than with short-acting benzodiazepines, which can make the onset of withdrawal somewhat more gradual and, in some respects, the withdrawal somewhat less abrupt. In fact, long-acting benzodiazepines are sometimes preferred or used in managing benzodiazepine withdrawal precisely because their slow clearance produces a smoother decline. However, this does not mean Onfi can be stopped suddenly; it must still be stopped gradually, by tapering under medical supervision, because, as a benzodiazepine, abrupt discontinuation after regular use can still cause a dangerous withdrawal.
This brings us to the crucial point that Onfi is a benzodiazepine and, like others in the class, carries real risks of tolerance, physical dependence, and addiction with regular use, and a potentially dangerous withdrawal if stopped abruptly. With regular use, the body adapts to clobazam, so that stopping it suddenly can cause a benzodiazepine withdrawal, which can include rebound symptoms, anxiety, agitation, and, in serious cases, seizures, and which is particularly important to avoid given that Onfi is often used to treat seizures in the first place. For this reason, Onfi must never be stopped abruptly after regular use but reduced gradually under medical supervision, and it should be taken only as prescribed. The long half-life affects the pattern of withdrawal but does not remove the need for careful, gradual, medically supervised stopping.
Summary
Onfi, the brand name for clobazam, is a long-acting benzodiazepine with a relatively long half-life, meaning it stays in the body for an extended time. The half-life of clobazam itself is generally around 36 to 42 hours, but importantly, clobazam is broken down into an active metabolite called norclobazam, which has a much longer half-life, often cited as around 71 to 82 hours, so the active drug effectively remains in the system considerably longer than the parent drug alone. This long half-life means Onfi builds up in the body with regular dosing, can usually be taken once or twice daily, and has effects that persist over a long period, which is part of why it is useful for ongoing conditions such as certain seizures. It also means the drug clears the body slowly after stopping, which can make withdrawal somewhat more gradual than with short-acting benzodiazepines, though stopping must still be done by tapering under medical supervision. Onfi is a benzodiazepine and, like others in the class, carries risks of tolerance, dependence, and a dangerous withdrawal if stopped abruptly, so it should be taken only as prescribed and never stopped suddenly after regular use.
As Dr. Ponlawat Pitsuwan, addiction medicine specialist at Phuket Island Rehab, puts it, “The key to understanding Onfi’s half-life is its active metabolite. Clobazam itself lasts a day and a half or so, but it turns into norclobazam, which hangs around for three days or more, so the drug is genuinely long-acting. That is why it works once or twice a day and builds up steadily, which suits ongoing seizure control. The long half-life also makes its withdrawal a bit smoother than a short-acting benzo, but, and this is the part people must not miss, it is still a benzodiazepine, so you never stop it cold, you taper it under medical care, because abrupt withdrawal can cause seizures, which is doubly serious in someone taking it for epilepsy.”
Frequently asked questions
What is the half-life of Onfi (clobazam)?
The half-life of clobazam itself is generally in the region of around 36 to 42 hours, making it a long-acting benzodiazepine. However, the full picture is longer, because clobazam is broken down into an active metabolite called norclobazam, which has a much longer half-life, often cited as around 71 to 82 hours. Because this active metabolite remains in the body much longer and contributes to the drug’s effects, the active drug effectively stays in the system considerably longer than the half-life of clobazam alone would suggest. So Onfi is a long-acting benzodiazepine whose duration is governed significantly by its long-lasting active metabolite, which is why it builds up with regular dosing and has sustained, prolonged effects.
How long does Onfi stay in your system?
Because of its long half-life and its long-acting active metabolite norclobazam (with a half-life often cited around 71 to 82 hours), Onfi stays in the system for an extended time, considerably longer than the roughly 36 to 42 hour half-life of clobazam alone would suggest. As a general principle, a drug is largely cleared after about five half-lives, so, accounting for the long-acting metabolite, clobazam and its effects can persist for a number of days after the last dose. The exact time varies between individuals depending on factors such as metabolism, liver function, dose, and how long it has been taken. This slow clearance is part of why the drug builds up with regular dosing and why its withdrawal is somewhat more gradual than with short-acting benzodiazepines.
Why does Onfi have a long-acting effect?
Onfi has a long-acting effect mainly because of its active metabolite, norclobazam, which the body produces when it breaks down clobazam and which has a much longer half-life (around 71 to 82 hours) than clobazam itself (around 36 to 42 hours). Because this metabolite is active and remains in the body for an extended time, it sustains the drug’s effects well beyond what clobazam alone would. This long-acting profile means Onfi builds up to a steady level with regular dosing, can be taken once or twice daily, and provides prolonged, steady effects, which suits its use for ongoing conditions such as certain seizures. So the long-acting nature is largely due to the long half-life of the active metabolite.
What does the long half-life mean for stopping Onfi?
Because clobazam and its active metabolite clear the body slowly, drug levels fall more gradually after stopping than with short-acting benzodiazepines, which can make the onset of withdrawal somewhat more gradual and the withdrawal somewhat less abrupt; long-acting benzodiazepines are sometimes used in managing withdrawal for this reason. However, this does not mean Onfi can be stopped suddenly. As a benzodiazepine, abrupt discontinuation after regular use can still cause a dangerous withdrawal, including seizures, which is especially important to avoid in someone taking it for epilepsy. So Onfi must still be stopped gradually, by tapering under medical supervision. The long half-life affects the pattern of withdrawal but does not remove the need for careful, gradual, medically supervised stopping.
Is Onfi (clobazam) addictive?
Onfi is a benzodiazepine and, like others in the class, carries real risks of tolerance, physical dependence, and addiction with regular use. With regular use, the body adapts to clobazam, so that stopping it suddenly can cause a benzodiazepine withdrawal, including rebound symptoms, anxiety, agitation, and, in serious cases, seizures. So while Onfi is a valuable medication for the seizures it treats, it should be used only as prescribed and not stopped abruptly after regular use, but reduced gradually under medical supervision. Anyone concerned about dependence on Onfi, or wishing to stop it, should discuss it with their doctor, who can manage a safe taper. As with all benzodiazepines, the dependence risk is real and means the drug must be used and stopped carefully.
What is Onfi used for?
Onfi (clobazam) is a benzodiazepine used particularly as an add-on treatment for seizures associated with a severe form of epilepsy, where its long-acting nature suits the need for steady, sustained seizure control over time. Benzodiazepines like clobazam act on the brain’s GABA system to reduce excessive nerve activity, which is how they help control seizures, as well as producing the calming, anti-anxiety, and sedative effects characteristic of the class. Onfi’s persistent effect and once- or twice-daily dosing are advantages for managing an ongoing condition like epilepsy. As a benzodiazepine, it should be taken exactly as prescribed and not stopped abruptly, given the risks of dependence and a dangerous withdrawal that can include seizures.
Sources
National Library of Medicine (MedlinePlus). Clobazam. https://medlineplus.gov/druginfo/meds/a612008.html
Food and Drug Administration (FDA). Onfi (clobazam) Prescribing Information. https://www.fda.gov/drugs
National Institute of Neurological Disorders and Stroke (NINDS). Epilepsy and Seizures. https://www.ninds.nih.gov/
National Institute on Drug Abuse (NIDA). Prescription CNS Depressants DrugFacts. https://nida.nih.gov/publications/drugfacts/prescription-cns-depressants
National Library of Medicine (PubMed). Clobazam and Norclobazam Pharmacokinetics. https://pubmed.ncbi.nlm.nih.gov/
Substance Abuse and Mental Health Services Administration (SAMHSA). Benzodiazepines and Treatment. https://www.samhsa.gov/
Onfi half-life — key entities and related terms
onfi half life, Onfi, clobazam, benzodiazepine, half-life, elimination half-life, long-acting benzodiazepine, active metabolite, norclobazam, N-desmethylclobazam, metabolism, liver, GABA, central nervous system, accumulation, steady state, build-up, dosing, once daily, twice daily, sustained effect, duration of action, clearance, how long it stays in the system, seizures, epilepsy, Lennox-Gastaut syndrome, add-on treatment, anti-anxiety, sedative, tolerance, physical dependence, addiction, benzodiazepine withdrawal, rebound symptoms, anxiety, agitation, seizures, abrupt discontinuation, tapering, gradual reduction, medically supervised detox, overdose, alcohol, opioids, doctor, healthcare provider, MedlinePlus, FDA, NINDS, NIDA, PubMed, SAMHSA, Phuket Island Rehab, Dr. Ponlawat Pitsuwan, may, side, take, use, provider, cause, symptoms, treatment, healthcare, away, drugs, taking